Improving Efficiency In Cell Line Development

The global market for biological products is growing, however the cost of developing a biologic drug remains high due to complex process development and manufacturing requirements. The success of a program hinges on the production of dedicated cell lines and early identification of top performers, as high yield products with optimal critical quality attributes significantly reduce production costs. Media and culture conditions are optimized to achieve higher cell growth and molecule yield.

Improve our cell line development (CLD) process by eliminating bottlenecks in clone selection, fast-tracking development timelines, and reducing the cost per experiment with these solutions.